Global Presbyopia Market is valued at approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. Presbyopia is a condition in which an individual's eyes lose their ability to focus on nearby objects. The growing investment in healthcare infrastructure, rising number of geriatric populations, and increasing incidences of presbyopia are primary factors contributing to the market growth on a global scale. For instance, as per the Department of Economic and Social Affairs, in 2019, the global population aged 65 and more is accounted for around 703 million. Also, the number of elderly people is expected to increase to 1.5 billion by 2050. Therefore, the geriatric population is more prone to vision loss and aging adults (age 40 or more years) are offering various growth prospects to the market, which stimulate the market growth across the globe. However, the dearth of skilled professionals and unavailability of advanced healthcare infrastructure in emerging economies impede the growth of the market over the forecast period of 2022-2028. Also, the rising investment in the advancing of innovative technologies and increasing research and development activities are anticipated to act as catalyzing factors for the market demand during the forecast period.
The key regions considered for the global Presbyopia Market study include: Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to the growing spending on healthcare facilities, along with increasing investment in technological developments for advanced presbyopia treatment. Whereas, Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2022-2028. Factors such as the increasing geriatric population, as well as, rising availability of better healthcare facilities, would create lucrative growth prospects for the Presbyopia Market across the Asia-Pacific region.
Major market players included in this report are:
- Visus Therapeutics
- Novartis
- Lenz Therapeutics
- Arctic Vision
- Orasis
- Ocuphire Pharma
- Presbia PLC
- MAG Optics Inc.
- PixelRo
- LensGen
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Symptoms:
- Eye Strain
- Headaches
- Fatigue
- Blurred Vision
- Others
By Treatment:
- Eyeglasses
- Contact Lenses
- Refractive Surgery
- Others
By Region:
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
Furthermore, years considered for the study are as follows:
- Historical year - 2018, 2019, 2020
- Base year - 2021
- Forecast period - 2022 to 2028
Target Audience of the Global Presbyopia Market in Market Study:
- Key Consulting Companies & Advisors
- Large, medium-sized, and small enterprises
- Venture capitalists
- Value-Added Resellers (VARs)
- Third-party knowledge providers
- Investment bankers
- Investors
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
- 1.2.1. Presbyopia Market, by Region, 2020-2028 (USD Million)
- 1.2.2. Presbyopia Market, by Symptoms, 2020-2028 (USD Million)
- 1.2.3. Presbyopia Market, by Treatment, 2020-2028 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Presbyopia Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Presbyopia Market Dynamics
- 3.1. Presbyopia Market Impact Analysis (2020-2028)
- 3.1.1. Market Drivers
- 3.1.1.1. Rising number of geriatric populations
- 3.1.1.2. Increasing incidences of presbyopia
- 3.1.2. Market Challenges
- 3.1.2.1. Dearth of skilled professionals
- 3.1.2.2. Unavailability of advanced healthcare infrastructure in emerging economies
- 3.1.3. Market Opportunities
- 3.1.3.1. Rising investment for the advancing of innovative technologies
- 3.1.3.2. Increasing research and development activities
Chapter 4. Global Presbyopia Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
- 4.2. PEST Analysis
- 4.2.1. Political
- 4.2.2. Economical
- 4.2.3. Social
- 4.2.4. Technological
- 4.3. Investment Adoption Model
- 4.4. Analyst Recommendation & Conclusion
- 4.5. Top investment opportunity
- 4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1.1. Assessment of the overall impact of COVID-19 on the industry
- 5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Presbyopia Market, by Symptoms
- 6.1. Market Snapshot
- 6.2. Global Presbyopia Market by Symptoms, Performance - Potential Analysis
- 6.3. Global Presbyopia Market Estimates & Forecasts by Symptoms, 2018-2028 (USD Million)
- 6.4. Presbyopia Market, Sub Segment Analysis
- 6.4.1. Eye Strain
- 6.4.2. Headaches
- 6.4.3. Fatigue
- 6.4.4. Blurred Vision
- 6.4.5. Others
Chapter 7. Global Presbyopia Market, by Treatment
- 7.1. Market Snapshot
- 7.2. Global Presbyopia Market by Treatment, Performance - Potential Analysis
- 7.3. Global Presbyopia Market Estimates & Forecasts by Treatment, 2018-2028 (USD Million)
- 7.4. Presbyopia Market, Sub Segment Analysis
- 7.4.1. Eyeglasses
- 7.4.2. Contact Lenses
- 7.4.3. Refractive Surgery
- 7.4.4. Others
Chapter 8. Global Presbyopia Market, Regional Analysis
- 8.1. Presbyopia Market, Regional Market Snapshot
- 8.2. North America Presbyopia Market
- 8.2.1. U.S. Presbyopia Market
- 8.2.1.1. Symptoms breakdown estimates & forecasts, 2018-2028
- 8.2.1.2. Treatment breakdown estimates & forecasts, 2018-2028
- 8.2.2. Canada Presbyopia Market
- 8.3. Europe Presbyopia Market Snapshot
- 8.3.1. U.K. Presbyopia Market
- 8.3.2. Germany Presbyopia Market
- 8.3.3. France Presbyopia Market
- 8.3.4. Spain Presbyopia Market
- 8.3.5. Italy Presbyopia Market
- 8.3.6. Rest of Europe Presbyopia Market
- 8.4. Asia-Pacific Presbyopia Market Snapshot
- 8.4.1. China Presbyopia Market
- 8.4.2. India Presbyopia Market
- 8.4.3. Japan Presbyopia Market
- 8.4.4. Australia Presbyopia Market
- 8.4.5. South Korea Presbyopia Market
- 8.4.6. Rest of Asia Pacific Presbyopia Market
- 8.5. Latin America Presbyopia Market Snapshot
- 8.5.1. Brazil Presbyopia Market
- 8.5.2. Mexico Presbyopia Market
- 8.6. Rest of The World Presbyopia Market
Chapter 9. Competitive Intelligence
- 9.1. Top Market Strategies
- 9.2. Company Profiles
- 9.2.1. Visus Therapeutics
- 9.2.1.1. Key Information
- 9.2.1.2. Overview
- 9.2.1.3. Financial (Subject to Data Availability)
- 9.2.1.4. Product Summary
- 9.2.1.5. Recent Developments
- 9.2.2. Novartis
- 9.2.3. Lenz Therapeutics
- 9.2.4. Arctic Vision
- 9.2.5. Orasis
- 9.2.6. Ocuphire Pharma
- 9.2.7. Presbia PLC
- 9.2.8. MAG Optics Inc.
- 9.2.9. PixelRo
- 9.2.10. LensGen
Chapter 10. Research Process
- 10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
- 10.2. Research Attributes
- 10.3. Research Assumption